本頁面由Tiger Trade Technology Pte. Ltd.提供服務

德納維製藥

15.50
0.0000
成交量:- -
成交額:1.10億
市值:17.67億
市盈率:-43.12
高:15.50
開:15.50
低:15.50
收:15.50
52周最高:15.73
52周最低:9.20
股本:1.14億
流通股本:1.14億
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.3595
每股收益(LYR):0.2000
淨資產收益率:-7.14%
總資產收益率:1.20%
市淨率:3.31
市盈率(LYR):77.50

資料載入中...

2024/08/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/02

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]